Osteoporosis is defined as a systemic skeletal disease characterized by low bone mass and
microarchitectural deterioration of bone tissue, with a consequent increase in bone fragility …

Osteoporosis (OP) is one of the most significant causes of morbidity, particularly in post-
menopausal women and older men. Despite its remarkable occurrence, the search for an …

Osteoporosis is a pathological condition characterized by an accelerated bone resorption
rate, resulting in decreased bone density and increased susceptibility to fractures …

Bone diseases include a wide group of skeletal-related disorders that cause mobility
limitations and mortality. In some cases, eg, in osteosarcoma (OS) and metastatic bone …

Bone diseases such as rheumatoid arthritis, Paget's disease, and osteoporosis cause
mortality and mobility limits. Nanomedicine and nano delivery systems have been utilised to …

Osteoporosis is characterised by a major public health burden, particularly taking into
account the ageing global population. Therapeutic modalities for osteoporosis are …

Injectable hydrogel-based materials have emerged as promising alendronate (ALN) delivery
systems for the treatment of osteoporosis. However, their intrinsic permeability limits the …

Osteoporosis is a skeletal disorder characterized by a low bone mass and density.
Alendronate (Alen), a second-generation bisphosphonate drug, was indicated as the first …

Alendronate (ALN) is the most commonly prescribed oral nitrogen-containing
bisphosphonate for osteoporosis therapy. However, its administration is associated with …

Background and objectives: Alendronate sodium (ALS) is the most common drug used for
the treatment of osteoporosis. The challenges facing ALS use include: very poor oral …